Solution structure of amyloid β-peptide (25-35) in different media

被引:115
|
作者
D'Ursi, AM
Armenante, MR
Guerrini, R
Salvadori, S
Sorrentino, G
Picone, D
机构
[1] Univ Naples Federico II, Dipartimento Chim, I-80126 Naples, Italy
[2] Univ Naples Parthenope, I-80133 Naples, Italy
[3] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
[4] Univ Salerno, Dipartimento Sci Farmaceut, I-84084 Fisciano, Italy
关键词
D O I
10.1021/jm040773o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril formation or as inhibitors of amyloid membrane pore formation represents one of the most relevant approaches in the development of anti-Alzheimer therapies. Abeta-(25-35), sequence GSNKGAIIGLM, is a highly toxic synthetic derivative of amyloid beta-peptides (Abeta-peptides), which forms fibrillary aggregates. Here, we report the NMR and CD investigation of A,beta-(2535) in a membrane-mimicking environment and in isotropic mixtures of water and fluoroalcohols to scan its conformational properties as a function of the medium. The analysis of the 3D structures in the mentioned conditions indicates a propensity of the peptide to behave as a typical transmembrane helix in the lipidic environment. In media characterized by different polarity, it loses the structural regularity at specific points of the sequence as a function of the environment. Furthermore, a comparison with the solution structure of full-length amyloid peptides suggests a role for the 25-27 kink region, which appears to be a general feature of all peptides under the solution conditions explored.
引用
收藏
页码:4231 / 4238
页数:8
相关论文
共 50 条
  • [41] GABA transporter 2 expression in hippocampus after β-amyloid peptide (Aβ25-35) injection
    Takagi, Shoko
    Nishioka, Kasumi
    Ueda, Ryo
    Ibi, Daisuke
    Mamiya, Takayoshi
    Kojima, Ryoji
    Hiramatsu, Masayuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S231 - S231
  • [42] β-amyloid peptide (25-35) as a tool for in vivo modelling Alzheimer's disease in rats
    Stepanichev, MY
    Onufriev, MV
    Moiseeva, YV
    Lazareva, NA
    Alessenko, AV
    Victorov, IV
    Gulyaeva, NV
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 : 19 - 19
  • [43] Interaction of the β amyloid - Aβ(25-35) - peptide with zwitterionic and negatively charged vesicles with and without cholesterol
    Singh, Jasmeet
    Peric, Miroslav
    CHEMISTRY AND PHYSICS OF LIPIDS, 2018, 216 : 39 - 47
  • [44] Central administration of amyloid β-peptide (25-35) and individual features of cognitive behavior in rats
    Mugantseva E.A.
    Podolskii I.Ya.
    Neuroscience and Behavioral Physiology, 2010, 40 (9) : 964 - 968
  • [45] Spectroscopic investigation of Ginkgo biloba terpene trilactones and their interaction with amyloid peptide Aβ(25-35)
    He, Jiangtao
    Petrovic, Ana G.
    Dzyuba, Sergei V.
    Berova, Nina
    Nakanishi, Koji
    Polavarapu, Prasad L.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2008, 69 (04) : 1213 - 1222
  • [46] Intracellular mechanisms of amyloid β-peptide Aβ25-35 induced neurite outgrowth inhibition in vitro
    Larner, AJ
    ALZHEIMERS REPORTS, 1998, 1 (01): : 55 - 59
  • [47] Fibronectin modulation by Aβ amyloid peptide (25-35) in cultured astrocytes of newborn rat cortex
    Moreno-Flores, MT
    Martín-Aparicio, E
    Salinero, O
    Wandosell, F
    NEUROSCIENCE LETTERS, 2001, 314 (1-2) : 87 - 91
  • [48] Chemical degradation of beta-amyloid [25-35] peptide under physiological conditions
    Jost, K
    Varga, J
    Szabo, Z
    Penke, B
    Zarandi, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 141 - 141
  • [49] Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Aβ25-35 to erythrocytes
    Kosenko, E. A.
    Solomadin, I. N.
    Marov, N. V.
    Venediktova, N. I.
    Poghosyan, A. S.
    Kaminsky, Yu. G.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2008, 34 (05) : 586 - 592
  • [50] Electron microscopic study of the effect of fullerene on the formation of amyloid fibrils by the Aβ25-35 peptide
    Podlubnaya Z.A.
    Podol'Skii I.Ya.
    Shpagina M.D.
    Marsagishvili L.G.
    Biophysics, 2006, 51 (5) : 701 - 704